ArticleCellular oncology (Dordrecht, Netherlands)2025

TRPV4 drives the progression of leiomyosarcoma by promoting ECM1 generation and co-activating the FAK/PI3K/AKT/GSK3β pathway.

Qiwen Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.